Flibanserin is a medication approved for the treatment of hypoactive sexual desire disorder in premenopausal women. It functions as a selective serotonin receptor agonist and antagonist, primarily targeting 5-ht1a receptors and 5-ht2a receptors. By modulating serotonin activity in specific brain regions, it enhances sexual desire without directly affecting hormonal levels. The drug works by increasing dopamine release and reducing norepinephrine tone, resulting in a net increase in sexual motivation. Its effect is achieved through central nervous system pathways that regulate arousal and emotional response. Clinical studies have shown modest improvements in sexual desire scores compared with placebo.

Flibanserin is a non-hormonal medication developed for the treatment of hypoactive sexual desire disorder in premenopausal women. It acts as a selective serotonin receptor antagonist and stimulates dopamine release to increase sexual desire. The drug works by modulating neurotransmitter activity in the brain regions associated with sexual motivation. Its pharmacological profile includes partial agonism at the 5-ht1a receptor and antagonism at the 5-ht2a receptor. Through these interactions Flibanserin reduces inhibitory serotonergic tone while enhancing excitatory dopaminergic signaling. This combined effect leads to an increase in sexual desire and satisfaction without directly affecting libido through hormonal pathways. The medication's primary therapeutic role is to provide a pharmacological option for women seeking improvement in sexual desire deficits.

Many patients report headache as a frequent reaction. Some experience fatigue that may affect daily activities. Nausea is also commonly observed. Dizziness can occur especially after the first dose. Dry mouth is reported by a notable number of users. Mild swelling at the injection site is another typical effect.

The most common side effects are usually mild and short lived. They often include headache fatigue and dizziness. Some people may experience mild nausea dry mouth or a low grade fever. These reactions typically resolve without medical intervention. Severity can vary between individuals and with dosage. Understanding these effects helps patients follow treatment plans safely.